NCT06666634View on ClinicalTrials.gov

Validation of ICG-99mTc-nanoscan as Hybrid Tracer for Sentinel Node Biopsy

NARecruitingINTERVENTIONAL

Enrollment

29

Participants

Timeline

Start Date

April 1, 2023

Primary Completion Date

August 31, 2025

Study Completion Date

August 31, 2025

Conditions

Penile CancerMelanomaOral Cancer

Interventions

DRUG

Sentinel node biopsy with either ICG-99mTc-nanoscan or 99mTc-nanoscan

Sentinel node biopsy with either ICG-99mTc-nanoscan or 99mTc-nanoscan

Trial Locations (1)

Unknown

RECRUITING

NKI-AVL, Amsterdam

All Listed Sponsors

lead

The Netherlands Cancer Institute

OTHER